| 查看: 255 | 回复: 3 | ||
| 【奖励】 本帖被评价3次,作者jackiemwd增加金币 2.5 个 | ||
| 当前主题已经存档。 | ||
[资源]
[转贴]Drug Safety Evaluation-1007页[已搜索无重复]
|
||
|
Drug Safety Evaluation Publisher: Wiley-Interscience Number Of Pages: 1007 Publication Date: 2002-04-15 Sales Rank: 340962 ISBN / ASIN: 0471407275 EAN: 9780471407270 Binding: Hardcover Manufacturer: Wiley-Interscience Studio: Wiley-Interscience Drug Safety Evaluation presents an all-inclusive, practical guide for those who are responsible for ensuring the safety of drugs and biologics for patients, for health care providers, for those involved in the manufacture of medicinal products, and for all those who need to understand how the safety of these products is evaluated. Individual chapters address specific approaches to evaluating hazards, including problems that are encountered and their solutions. Author Shayne Gad draws upon over twenty years of experience in toxicology, drug development, and risk assessment, explaining the scientific and philosophical bases for evaluating specific concerns (carcinogenicity, development toxicity, etc.) to provide both understanding and guidance for approaching new problems. Containing information specifically relevant to the pharmaceutical and biotechnology industries, Drug Safety Evaluation covers a wide variety of topics, including: Acute toxicity testing in pharmaceutical safety evaluation Genotoxicity Safety assessment of inhalant drugs Immunotoxicology in pharmaceutical development Large animal studies Evaluation of human tolerance and safety in clinical trials Drug Safety Evaluation provides a road map for safety assessment as an integral part of the development of new drugs and therapeutics. http://rapidshare.com/files/51388178/Wiley_.Drug.Safety.Evaluation._2002_._0471407275_.rar |
» 猜你喜欢
新加坡国立大学药学系化学生物学课题组招PhD
已经有14人回复
膳食补充剂合规性交流
已经有0人回复
药物学论文润色/翻译怎么收费?
已经有120人回复
请教酰胺缩合反应
已经有4人回复
一志愿大连理工制药工程专硕086002,本科211,总分342
已经有0人回复
一志愿浙大药学求调剂
已经有0人回复
高温高压反应求助
已经有4人回复
制药工程专业招收调剂,要求过国家线
已经有0人回复
五邑大学药物化学生物学团队-李兰清课题组招收调剂学生
已经有0人回复
药学B区求调剂
已经有0人回复
2楼2007-08-30 11:40:14














回复此楼